Literature DB >> 24758677

Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.

Yu-Hsiang Juan1, Sachin S Saboo, Sree Harsha Tirumani, Ashish Khandelwal, Atul B Shinagare, Nikhil Ramaiya, Katherine M Krajewski.   

Abstract

OBJECTIVE: The purpose of this article is to enlighten radiologists with the clinical presentation, multimodality imaging features, local recurrence, distant spread, differential diagnosis, and prognosis of skin and subcutaneous malignancies.
CONCLUSION: Cutaneous and subcutaneous malignancies represent the most common type of cancer and frequently present with overlapping imaging appearances. CT, MRI, and (18)F-FDG PET/CT are commonly used for staging, preoperative planning, and posttreatment assessment. Knowledge of the multimodality imaging features can narrow down the differential diagnosis and elucidate their metastatic pattern.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24758677     DOI: 10.2214/AJR.13.11424

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  F-18 FDG PET/CT Imaging of Eccrine Sweat Gland Carcinoma of the Scrotum with Extensive Regional and Distant Metastases.

Authors:  Jin-Suk Kim
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

Review 2.  Imaging of Abdominal Wall Masses, Masslike Lesions, and Diffuse Processes.

Authors:  David H Ballard; Parisa Mazaheri; Daniel C Oppenheimer; Meghan G Lubner; Christine O Menias; Perry J Pickhardt; William D Middleton; Vincent M Mellnick
Journal:  Radiographics       Date:  2020-04-24       Impact factor: 5.333

3.  Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.

Authors:  Mette Bordinggaard Brøndserud; Court Pedersen; Flemming S Rosenvinge; Poul F Høilund-Carlsen; Søren Hess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-20       Impact factor: 9.236

4.  Bilateral multifocal lower extremity localized soft tissue amyloidomas: case report with ultrasonographic characterization.

Authors:  Tanner C Clark; Bart Kimbrell; Nicole Girard; Barry G Hansford
Journal:  Skeletal Radiol       Date:  2017-09-30       Impact factor: 2.199

5.  Small Subcutaneous Soft Tissue Tumors (<5 cm) Can Be Sarcomas and Contrast-Enhanced Ultrasound (CEUS) Is Useful to Identify Potentially Malignant Masses.

Authors:  Armanda De Marchi; Simona Pozza; Lorena Charrier; Filadelfo Cannone; Franco Cavallo; Alessandra Linari; Raimondo Piana; Irene Geniò; Paolo Balocco; Alessandro Massè
Journal:  Int J Environ Res Public Health       Date:  2020-11-28       Impact factor: 3.390

Review 6.  Imaging features of primary sites and metastatic patterns of angiosarcoma.

Authors:  Basrull N Bhaludin; Khin Thway; Margaret Adejolu; Alexandra Renn; Christian Kelly-Morland; Cyril Fisher; Robin L Jones; Christina Messiou; Eleanor Moskovic
Journal:  Insights Imaging       Date:  2021-12-18

Review 7.  Imaging findings of malignant skin tumors: radiological-pathological correlation.

Authors:  Masaya Kawaguchi; Hiroki Kato; Yoshifumi Noda; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Fuminori Hyodo; Masayuki Matsuo
Journal:  Insights Imaging       Date:  2022-03-22

Review 8.  MRI techniques for immunotherapy monitoring.

Authors:  Doreen Lau; Pippa G Corrie; Ferdia A Gallagher
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

9.  Advanced Magnetic Resonance Imaging in the Evaluation of a Chronic Non-healing ulcer - A Case Report of Rare Primary Cutaneous Leiomyosarcoma.

Authors:  Vandana V Ahluwalia; Pratish Kumar Singh; Hari Singh; Sunanda Samanta
Journal:  J Orthop Case Rep       Date:  2018 Jul-Aug

10.  Magnetic Resonance Imaging Findings Differentiating Cutaneous Basal Cell Carcinoma from Squamous Cell Carcinoma in the Head and Neck Region.

Authors:  Masaya Kawaguchi; Hiroki Kato; Hiroyuki Tomita; Akira Hara; Natsuko Suzui; Tatsuhiko Miyazaki; Kanako Matsuyama; Mariko Seishima; Masayuki Matsuo
Journal:  Korean J Radiol       Date:  2020-03       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.